Artigo · Revista · 2021

Structural insights into the molecular design of ROS1 inhibitor for the treatment of non-small cell lung cancer (NSCLC)

Current Computer-Aided Drug Design

Autores

1 autor

Structural insights into the molecular design of ROS1 inhibitor for the treatment of non-small cell lung cancer (NSCLC) · Peerford